Literature DB >> 19451280

Effects of azithromycin in combination with vancomycin, daptomycin, fosfomycin, tigecycline, and ceftriaxone on Staphylococcus epidermidis biofilms.

Elisabeth Presterl1, Stefan Hajdu, Andrea M Lassnigg, Alexander M Hirschl, Johannes Holinka, Wolfgang Graninger.   

Abstract

Staphylococcal biofilms on surgical implants are the underlying cause of a lack of response to antimicrobial treatment. We investigated the effects of vancomycin (VAN), daptomycin (DAP), fosfomycin (FOS), tigecycline (TGC), and ceftriaxone (CRX), alone and in combination with azithromycin (AZI), on established biofilms of Staphylococcus epidermidis. Biofilms were studied using the static microtiter plate model with established S. epidermidis biofilms, with an initial inoculum of 10(6)/ml in 96-well polystyrene flat-bottom microtiter plates. Biofilms were inoculated with VAN, DAP, FOS, TGC, or CRX at two concentrations, alone or in combination with AZI (2, 512, or 1,024 mg/liter). To assess the reduction in biomass, the optical density ratio (ODr), calculated as (optical density [OD] of the treated biofilm)/(OD of the untreated biofilm, taken as 1), was used. For antibacterial efficacy, the viable bacterial count was used. Reductions in the biofilm ODr were observed for VAN (15 and 40 mg/liter) and FOS (200 mg/liter) only (ODr [mean +/- standard deviation] for VAN at 15 and 40 mg/liter, 0.77 +/- 0.32 and 0.8 +/- 0.35, respectively; ODr for FOS at 200 mg/liter, 0.78 +/- 0.26; P < 0.05), but not for DAP (2 and 5 mg/liter), TGC (0.2 and 2 mg/liter), or CRX (600 and 2,400 mg/liter). The addition of AZI had no further effect on the ODr, but a significant reduction of bacterial growth was achieved with high doses of AZI plus TGC or AZI plus CRX (a 3-log count reduction for AZI at 1,024 mg/liter plus CRX at 600 mg/liter and for AZI at 512 or 1,024 mg/liter plus CRX at 2,400 mg/liter; a 2-log count reduction for AZI at 512 or 1,024 mg/liter plus TGC at 2 mg/liter [P < 0.05]). No significant reduction in bacterial growth was observed for FOS (50 and 200 mg/liter), DAP (2 and 5 mg/liter), or TGC (0.2 mg/liter) in combination with AZI. None of the antibiotics at either concentration reduced the bacterial count of the biofilms when used alone. Thus, the use of a combination of AZI plus TGC, FOS, or CRX at high concentrations has little effect on biofilm density but significantly reduces bacterial growth.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19451280      PMCID: PMC2715620          DOI: 10.1128/AAC.01628-08

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  37 in total

Review 1.  Coagulase-negative staphylococci as a cause of infections related to intravascular prosthetic devices: limitations of present therapy.

Authors:  T Schulin; A Voss
Journal:  Clin Microbiol Infect       Date:  2001       Impact factor: 8.067

Review 2.  Efficacy of antiadhesive, antibiotic and antiseptic coatings in preventing catheter-related infections: review.

Authors:  G Donelli; I Francolini
Journal:  J Chemother       Date:  2001-12       Impact factor: 1.714

Review 3.  Mechanical circulatory assistance for acute and chronic heart failure: a review of current technology and clinical practice.

Authors:  Michael P Siegenthaler; Jürgen Martin; Friedhelm Beyersdorf
Journal:  J Interv Cardiol       Date:  2003-12       Impact factor: 2.279

Review 4.  Treatment of infections associated with surgical implants.

Authors:  Rabih O Darouiche
Journal:  N Engl J Med       Date:  2004-04-01       Impact factor: 91.245

5.  Effects of subinhibitory concentrations of vancomycin or cefamandole on biofilm production by coagulase-negative staphylococci.

Authors:  W M Dunne
Journal:  Antimicrob Agents Chemother       Date:  1990-03       Impact factor: 5.191

6.  Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices.

Authors:  G D Christensen; W A Simpson; J J Younger; L M Baddour; F F Barrett; D M Melton; E H Beachey
Journal:  J Clin Microbiol       Date:  1985-12       Impact factor: 5.948

7.  Biofilm bacteria: formation and comparative susceptibility to antibiotics.

Authors:  Merle E Olson; Howard Ceri; Douglas W Morck; Andre G Buret; Ronald R Read
Journal:  Can J Vet Res       Date:  2002-04       Impact factor: 1.310

Review 8.  Laboratory, clinical, and epidemiological aspects of coagulase-negative staphylococci.

Authors:  M A Pfaller; L A Herwaldt
Journal:  Clin Microbiol Rev       Date:  1988-07       Impact factor: 26.132

9.  Biofilm testing of Staphylococcus epidermidis clinical isolates: low performance of vancomycin in relation to other antibiotics.

Authors:  Marta Monzón; Concepción Oteiza; José Leiva; Marta Lamata; Beatriz Amorena
Journal:  Diagn Microbiol Infect Dis       Date:  2002-12       Impact factor: 2.803

10.  Effects of alcohols, povidone-iodine and hydrogen peroxide on biofilms of Staphylococcus epidermidis.

Authors:  Elisabeth Presterl; Miranda Suchomel; Michaela Eder; Sonja Reichmann; Andrea Lassnigg; Wolfgang Graninger; Manfred Rotter
Journal:  J Antimicrob Chemother       Date:  2007-06-22       Impact factor: 5.790

View more
  5 in total

1.  Increased temperature enhances the antimicrobial effects of daptomycin, vancomycin, tigecycline, fosfomycin, and cefamandole on staphylococcal biofilms.

Authors:  Stefan Hajdu; Johannes Holinka; Sonja Reichmann; Alexander M Hirschl; Wolfgang Graninger; Elisabeth Presterl
Journal:  Antimicrob Agents Chemother       Date:  2010-08-02       Impact factor: 5.191

2.  [Management of prosthetic joint infections].

Authors:  J Holinka; R Windhager
Journal:  Orthopade       Date:  2016-04       Impact factor: 1.087

Review 3.  Fosfomycin.

Authors:  Matthew E Falagas; Evridiki K Vouloumanou; George Samonis; Konstantinos Z Vardakas
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

4.  Adjuvant antibiotic-loaded bone cement: Concerns with current use and research to make it work.

Authors:  Edward M Schwarz; Alex C McLaren; Thomas P Sculco; Barry Brause; Mathias Bostrom; Stephen L Kates; Javad Parvizi; Volker Alt; William V Arnold; Alberto Carli; Antonia F Chen; Hyonmin Choe; Débora C Coraça-Huber; Michael Cross; Michelle Ghert; Noreen Hickok; Jessica Amber Jennings; Manjari Joshi; Willem-Jan Metsemakers; Mark Ninomiya; Kohei Nishitani; Irvin Oh; Douglas Padgett; Benjamin Ricciardi; Kordo Saeed; Parham Sendi; Bryan Springer; Paul Stoodley; Joseph C Wenke
Journal:  J Orthop Res       Date:  2020-03-02       Impact factor: 3.102

5.  Evaluation of High-Dose Daptomycin Versus Vancomycin Alone or Combined with Clarithromycin or Rifampin Against Staphylococcus aureus and S. epidermidis in a Novel In Vitro PK/PD Model of Bacterial Biofilm.

Authors:  Ashley D Hall Snyder; Celine Vidaillac; Warren Rose; John P McRoberts; Michael J Rybak
Journal:  Infect Dis Ther       Date:  2014-12-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.